Skip to main content
. 2018 Jul 25;130(15):468–478. doi: 10.1007/s00508-018-1361-9

Fig. 2.

Fig. 2

Patient 10, neurocognitive assessment. Solid lines: WMS-R subtests; round dots: CERAD-Plus subtests: BNT Boston naming test, TMT Trail making test, VF verbal fluency; dash-dot lines: IP ideomotor praxia, MT Memo test TX: antibiotic treatment; violet field: normal range (z-score −1 to +1); TMT-B z‑score for Pre-TX not shown, calculation due to delayed performance (598 s) not meaningful